Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06720571

Effects of Transcutaneous Vagus Nerve Stimulation on Emotion Regulation and Executive Functioning in Prader-Willi Syndrome

Led by University of Bordeaux · Updated on 2024-12-06

24

Participants Needed

4

Research Sites

122 weeks

Total Duration

On this page

Sponsors

U

University of Bordeaux

Lead Sponsor

J

John Bost Foundation

Collaborating Sponsor

AI-Summary

What this Trial Is About

The STIM-PRADER study aims to assess the effectiveness of auricular vagal neuromodulation therapy (aVNT) on emotional, behavioral, and cognitive domains impaired in Prader-Willi Syndrome (PWS). Currently, no treatment exists that addresses the multiple alterations associated with this rare neurodevelopmental disorder that significantly impact patients and their families. We will investigate the effects of daily, four-hour aVNT stimulation over a nine-month period on (a) emotion regulation, including assessing the persistence of effects following stimulation; (b) executive functions, including inhibition, flexibility, planning, and updating information in memory; (c) hyperphagia; (d) depression; (e) quality of life; (e) and the threshold at which effects on these dimensions can be observed. We will conduct a longitudinal multicenter parallel randomized controlled single-blind exploratory trial. Twenty-four adults with PWS and 24 caregivers will be randomly assigned to receive either active or sham stimulation under identical conditions (four hours per day, seven days per week over nine months). The primary outcome, focusing on emotional control, will be assessed every two weeks for both participants and caregivers. Secondary outcomes (executive functions, hyperphagia, depression, and quality of life) will be measured at four time points: pre-intervention, at three months, six months, and at nine months. As this is the first multicenter randomized controlled trial investigating the effects of aVNT as a treatment in PWS patients, we anticipate witnessing improved emotional regulation and reduced eating disorders, along with enhancements in executive functions and quality of life in the active stimulation group. The findings from this project could support the development of broader therapeutic approaches for other conditions in which behavioral disorders and emotional processing deficits affect patients and their caregivers.

CONDITIONS

Official Title

Effects of Transcutaneous Vagus Nerve Stimulation on Emotion Regulation and Executive Functioning in Prader-Willi Syndrome

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 years or older with diagnosed Prader-Willi Syndrome confirmed by genotype
  • Intellectual Quotient of 55 or higher measured by WAIS-IV (abbreviated version)
  • Pathological or threshold score on at least one BRIEF-A subscale
  • Adults able and willing to comply with study procedures
  • Signed informed consent form
  • Beneficiary of a social security regime
  • Caregivers involved in the participant's family, medical, or institutional environment
  • Caregivers who have signed the informed consent form
Not Eligible

You will not qualify if you...

  • Untreated or unstable psychiatric and/or behavioral disorders including psychological decompensation within the last year
  • Severe visual or hearing impairment
  • Untreated sleep apnea syndrome
  • Epileptic seizures
  • Significant ECG abnormalities
  • Presence of pacemakers or defibrillators
  • Metal or electronic devices implanted in the head
  • Participation in other research with an exclusion period still ongoing
  • Severe depression indicated by a BDI-II self-report score of 30 or higher
  • Pregnant or breastfeeding women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Reference Center of Prader-Willi Syndrome (PRADORT)

Bordeaux, France, 33600

Not Yet Recruiting

2

Reference Center of Prader-Willi Syndrome (CRMR PRADORT)

Hendaye, France, 64700

Actively Recruiting

3

Reference Center of Prader-Willi Syndrome (PRADORT)

Paris, France, 75013

Actively Recruiting

4

Reference Center of Prader-Willi Syndrome (PRADORT)

Toulouse, France, 31000

Actively Recruiting

Loading map...

Research Team

V

Virginie Postal, PhD

CONTACT

C

Camille Nahon, PhD student, neuropsychologist

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here